These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Lozano M, Cid J. Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772 [Abstract] [Full Text] [Related]
27. ABO-incompatible platelets are associated with increased transfusion reaction rates. Malvik N, Leon J, Schlueter AJ, Wu C, Knudson CM. Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889 [Abstract] [Full Text] [Related]
28. Acute haemolytic reaction secondary to an ABO minor mismatched platelet transfusion from a group A blood donor. Swain F, Daly J, Baidya S, Wilson B, Morrison J, Liew YW, Powley T, Jivan Y, Bryant S, Allen A, Crampton N. Transfus Med; 2019 Apr; 29(2):133-135. PubMed ID: 30900358 [No Abstract] [Full Text] [Related]
30. Apheresis platelet transfusions: does ABO matter? Herman JH, King KE. Transfusion; 2004 Jun; 44(6):802-4. PubMed ID: 15157242 [No Abstract] [Full Text] [Related]
31. Acute Intravascular Hemolysis Following an ABO Non-Identical Platelet Transfusion: A Case Report and Literature Review. Moinuddin IA, Millward P, Fletcher CH. Am J Case Rep; 2019 Jul 23; 20():1075-1079. PubMed ID: 31332158 [Abstract] [Full Text] [Related]
35. [Platelet antigens and antibodies against them]. Zotikov EA. Biull Eksp Biol Med; 2000 Mar 23; 129(3):244-7. PubMed ID: 10776555 [No Abstract] [Full Text] [Related]
36. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy. Pagano MB, Katchatag BL, Khoobyari S, Van Gerwen M, Sen N, Rebecca Haley N, Gernsheimer TB, Hess JR, Metcalf RA. Transfusion; 2019 Apr 23; 59(4):1246-1251. PubMed ID: 30592057 [Abstract] [Full Text] [Related]